Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Institutional Holder Has Liquidated More Than Five Percent Holding in MFIC

MFIC Corporation ("MFIC" or the "Company")(OTCBB: MFIC) announced today that it recently received notification that Pfizer Inc. ("Pfizer") had liquidated its position, approximately 600,000 shares, or approximately 6%, of the outstanding common stock of MFIC.

Institutional Holder Has Liquidated More Than Five Percent Holding in MFIC

NEWTON, MA | Posted on April 2nd, 2007

The Pfizer shares were acquired by its predecessor in interest, G.D. Searle, Inc.

In response to a questionnaire circulated in connection with the preparation of MFIC's 2007 Proxy Statement Pfizer supplied records indicating that it sold the shares in the public market in varying size lots between December 2005 and February 2007.


About MFIC Corporation
MFIC Corporation, through its Microfluidics Division, provides patented and proprietary high performance Microfluidizer® materials processing equipment to the biotechnology, pharmaceutical, chemical, cosmetics/personal care, and food industries. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products. MFIC applies its 20 years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid structures available, and has provided manufacturing systems for more than 15 years.

The Company is a leader in advanced materials processing equipment for laboratory, pilot scale and manufacturing applications, offering innovative technology and comprehensive solutions for nanoparticles and other materials processing and production. More than 3,000 systems are in use and afford significant competitive and economic advantages to MFIC equipment customers.

For more information, please click here

MFIC Corporation
Irwin Gruverman, CEO & Chairman
Robert P. Bruno, President & COO
Jack M. Swig, Investor Relations
Fax: 617-965-1213

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

Nanotech Grants Options September 22nd, 2016

Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016

Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016


How nanoscience will improve our health and lives in the coming years: Targeted medicine deliveries and increased energy efficiency are just two of many ways October 26th, 2016

Chad Mirkin receives nanotechnology prize in Russia October 26th, 2016

Imaging where cancer drugs go in the body could improve treatment October 26th, 2016

Precise quantum cloning: possible pathway to secure communication: Physicists create best ever quantum clones October 26th, 2016

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project